RPG Life Sciences Limited — Dividend/Bonus, 29-04-2026: Record Date

The Board has approved a dividend of ₹24 per equity share (300% on ₹8 face value) for FY26. This payout is subject to shareholder approval at the upcoming Annual General Meeting and will be processed within 30 days of that approval. Additionally, the Board reviewed the quarter and year-end financial results for March 31, 2026, and appointed Dr. Pratit Samdani as an Independent Director for five years, pending shareholder nod.